Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation

Area of Science:

• Endocrinology
• Immunology
• Metabolic Diseases

Background:

• High saturated fatty acid intake is linked to type 2 diabetes (T2D).
• Inflammation is implicated in insulin resistance, but its role in beta cell dysfunction is unclear.

Purpose of the Study:

• To elucidate the mechanism by which saturated fatty acids induce pancreatic beta cell dysfunction.
• To investigate the role of inflammation in saturated fatty acid-induced beta cell failure.

Main Methods:

• In vivo and in vitro studies using palmitate, a saturated fatty acid.
• Analysis of the Toll-like receptor 4 (TLR4)/MyD88 pathway in beta cells.
• Chemokine analysis and immune cell profiling (CD11b(+)Ly-6C(+) M1 monocytes/macrophages).
• Beta cell function assessment in mice with and without M1 cell depletion.

Main Results:

• Palmitate induces beta cell dysfunction in vivo by activating inflammatory pathways within islets.
• Beta cells activate the TLR4/MyD88 pathway in response to palmitate.
• Palmitate triggers chemokine production, recruiting M1 proinflammatory monocytes/macrophages to islets.
• Depletion of M1 cells protects against palmitate-induced beta cell dysfunction.
• Islet inflammation is crucial for beta cell dysfunction in T2D mouse models.

Conclusions:

• Saturated fatty acids, specifically palmitate, directly impair beta cell function through inflammation.
• The FFA-TLR4/MyD88 pathway mediates beta cell inflammation and dysfunction.
• Targeting islet inflammation may offer a therapeutic strategy for T2D.